Internal Medicine, Rheumatology · San Diego, CA
NPI
1730271933
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5030 Camino de la Siesta Ste 106
San Diego, CA, 92108
Phone (619) 334-4869
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.2M
389,813 services
Medicare patients, 2024
587
Average age 73
Drug cost, 2024
$7.5M
3,918 prescriptions
Company payments, 2025
$29K
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arthur R Mabaquiao was code J0174 (injection, lecanemab-irmb, 1 mg), 146,700 times for 14 patients. In total Arthur R Mabaquiao billed 389,813 services in 83 codes, and Medicare paid $5.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0174 Injection, lecanemab-irmb, 1 mg | Office | 146,700 | 14 | $1.05 | $154K |
| J3262 Injection, tocilizumab, 1 mg | Office | 60,470 | 12 | $4.70 | $284K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 46,800 | 14 | $3.61 | $169K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 23,941 | 22 | $8.53 | $204K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 18,650 | 19 | $9.09 | $170K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 16,425 | 25 | $33.84 | $556K |
| J0897 Injection, denosumab, 1 mg | Office | 11,340 | 119 | $20.47 | $232K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 9,985 | 104 | $0.10 | $1,005 |
| J1306 Injection, inclisiran, 1 mg | Office | 6,816 | 17 | $9.56 | $65K |
| J9312 Injection, rituximab, 10 mg | Office | 5,650 | 21 | $61.28 | $346K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,503 | 29 | $0.23 | $568 |
| 99212 Office E&M - Established | Office | 1,480 | 305 | $47.81 | $71K |
| 99214 Office E&M - Established | Office | 1,038 | 391 | $97.98 | $102K |
| 96372 Injection Administration | Office | 815 | 213 | $12.09 | $9,854 |
| 96365 Intravenous Infusion, Hydration | Office | 712 | 105 | $55.03 | $39K |
By year: 2022 $4.1M for 157,460 services; 2023 $4.5M for 203,046 services; 2024 $5.2M for 389,813 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arthur R Mabaquiao prescribed most often to Medicare patients was Prednisone, with 225 prescriptions and refills. In total Arthur R Mabaquiao wrote 3,918 Medicare prescriptions that cost $7.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 225 | 303 | 61 | $1,447 |
| Diclofenac Sodium Generic | 217 | 307 | 77 | $34K |
| Hydroxychloroquine Sulfate Generic | 193 | 457 | 61 | $15K |
| Pregabalin Generic | 164 | 296 | 47 | $3,993 |
| Celecoxib Generic | 164 | 287 | 46 | $8,735 |
| Methotrexate Methotrexate Sodium | 149 | 333 | 48 | $4,794 |
| Leflunomide Generic | 119 | 236 | 32 | $6,370 |
| Gabapentin Generic | 113 | 190 | 34 | $2,115 |
| Meloxicam Generic | 97 | 123 | 32 | $242 |
| Methylprednisolone Generic | 83 | 99 | 35 | $793 |
| Etodolac Generic | 82 | 100 | 22 | $2,370 |
| Tizanidine Hcl Generic | 82 | 97 | 21 | $735 |
| Colchicine Generic | 79 | 116 | 19 | $3,769 |
| Lidocaine Generic | 77 | 88 | 27 | $7,007 |
| Cyclobenzaprine Hcl Generic | 60 | 82 | 18 | $542 |
Brand drugs: - claims; generic drugs: 3,148 claims; opioid claims: 62.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arthur R Mabaquiao $29K ($29K in general payments such as food, travel and fees) from 35 companies. The largest payer was UCB, Inc. with $15K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 42 | $15K |
| Amgen Inc. AMGN | 67 | $8,320 |
| Abbvie Inc. ABBV | 55 | $1,054 |
| Janssen Biotech, Inc. JNJ | 37 | $935 |
| Mallinckrodt Hospital Products Inc. | 24 | $629 |
| ANI Pharmaceuticals, Inc. ANIP | 19 | $469 |
| Novartis Pharmaceuticals Corporation NVS | 26 | $449 |
| Lilly USA, LLC LLY | 8 | $269 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $264 |
| Pfizer Inc. PFE | 9 | $204 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.